Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|5|E77-E79

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.5, 2015-05, pp. : E77-E79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Mutations in Patients with Acute Myeloid Leukemia and Leukostasis

By  

Acta Haematologica, Vol. 130, Iss. 2, 2013-03 ,pp. : 95-97

Karger

Access to resources Recommend Favorite

Clinical Implications of Non-A-Type NPM1 and FLT3 Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 2, 2011-11 ,pp. : 63-71

Karger

Access to resources Recommend Favorite

Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 138, Iss. 1, 2017-06 ,pp. : 10-13

Karger

Access to resources Recommend Favorite

Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 330-338

John Wiley & Sons Inc

Access to resources Recommend Favorite

Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta‐analysis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 5, 2015-05 ,pp. : 439-448

John Wiley & Sons Inc

Access to resources Recommend Favorite